Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Securities and Exchange Commission

                    Boise Cascade Corporation (“Company”) has filed an application with the Securities and Exchange Commission (“Commission”), pursuant to Section 12(d) of the Securities Exchange Act of 1934 (“Act”) [1]                                          and Rule 12d2-2(d) thereunder,[2]                                          to withdraw its Common Stock, $2.50 par value, and associated Common Stock Purchase Rights (referred to collectively herein as the “Securities”),[3]                                          from listing and registration on the Chicago Stock Exchange, Incorporated (“CHX”).                

The Company, whose Securities are additionally listed on the New York Stock Exchange (“NYSE”), is seeking to withdraw the Securities from listing and registration on the CHX at this time in order to save the costs associated with such listing and related compliance. The Company's Common Stock has been listed for trading on the CHX since 1968, but in a recent review of its business conduct the Company found that the majority (more than 95%) of its Common Stock is traded on the NYSE. The Company's board of directors has therefore determined that no significant business reasons exist for maintaining the Securities' listing and registration on the CHX.

                    The Company has stated that its application relates solely to the withdrawal of the Securities from listing and registration on the CHX and shall have no effect upon the Securities' continued listing and registration on the NYSE under Section 12(b) of the Act.[4] 

The withdrawal of the Securities from listing and registration on the CHX was approved by the Company's board of directors at a meeting held on July 31, 1998, and a resolution so stating was forwarded to the CHX in accordance with its rules. The Company has included with its application a copy of a letter from the CHX confirming that the Company's request for withdrawal complies with the rules of the CHX governing an issuer's removal of securities from listing and registration on the CHX.

Any interested person may, on or before June 14, 2000, submit by letter to the Secretary of the Securities and Exchange Commission, 450 Fifth Street, NW, Washington, DC 20549-0609, facts bearing upon whether the application has been made in accordance with the rules of the CHX and what terms, if any, should be imposed by the Commission for the protection of investors. The Commission, based on the information submitted to it, will issue an order granting the application after the date mentioned above, unless the Commission determines to order a hearing on the matter.

                        For the Commission, by the Division of Market Regulation, pursuant to delegated authority.[5] 

Jonathan G. Katz, 

Secretary.

# Footnotes

1.                             15 U.S.C. 78*l*                        (d).                    
        Back to Citation      

2.                             17 CFR 240.12d2-2(d).                    
        Back to Citation      

3.                             The Common Stock Purchase Rights are currently attached to, and trade together with, the Company's Common Stock.                    
        Back to Citation      

4.                             15 U.S.C. 78*l*                        (b).                    
        Back to Citation      

5.                                 17 CFR 200.30-3(a)(1).                        
        Back to Citation      

[FR Doc. 00-13411  Filed 5-26-00; 8:45 am]

BILLING CODE 8010-01-M